The conference featured 81 distinguished speakers across 41 sessions, exploring a broad range of topics from cutting-edge research to practical industry applications in nanotechnology. Over 200 young attendees participated in the pre-conference tutorials.
During the two days sessions on "Nano in Healthcare", Prof. Dhirendra Katti, Director, IIT Goa spoke on 'Development of a Vaccines/Nano vaccines for Multi-drug Resistant Diarrhoea'; Dr Jiban Jyoti Panda, Associate Professor, Institute of Nano Science and Technology, Mohali spoke on 'Brain targeting Small Molecular Nanomedicines', Prof. Biman B. Mandal, Professor, IIT Guwahati shared his views on 'Nano-Composite Silk Hydrogel for Spatiotemporal, Targeted and On-Demand Controlled Release of Chemotherapeutics: An In Vivo Approach toward Suppressing Solid Tumour Growth', This session was chaired by Prof. Swaminathan, Professor & Director, SASTRA University.
Dr Praveen Kumar Vemula, Faculty, DBT INSTEM chaired a second session on Nano in Healthcare in which Prof. Neetu Singh, Professor & Head, Center for Biomedical Engineering, Indian Institute of Technology Delhi shared her views on the topic '3D Liver Platforms For In-Situ Disease Staging' and in his presentation Prof. Bikramjit Basu, Professor, IISc Bangalore touched upon 'Size-tailored Gold Nanoparticles: Novel electroactuators to guide stem cell differentiation and as bacteriotoxic agents' and Prof. K. Uma Maheswari, Professor, Sastra University spoke on Smart Non-intervention for Therapy.
Dr Taslimarif Syed, CEO and Director, C- CAMP, moderated a panel discussion on 'Healthcare & Medical Electronics' with Dr Aditya Kulkarni,
This story is from the September 2024 edition of Bio Spectrum.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the September 2024 edition of Bio Spectrum.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Agilent releases nextgen HPLC systems with enhanced automation and sustainability capabilities
Agilent Technologies Inc. has announced the release of its next generation Agilent InfinityLab LC Series portfolio, which includes the 1290 Infinity III LC, 1260 Infinity III Prime LC, and 1260 Infinity III LC systems, all including the biocompatible versions.
Univercells Technologies launches miniaturised scale-X Nexo Bioreactor
Univercells Technologies has announced the launch of its latest innovation, the scale-X nexo bioreactor.
Thermo Fisher and Telangana to establish Bioprocess Design Centre for novel biotherapeutics
Thermo Fisher Scientific has announced the signing of a Memorandum of Understanding (MoU) with the Government of Telangana to establish a Bioprocess Design Centre (BDC) in Genome Valley, Hyderabad.
VFL Sciences announces launch of GreatFlo Parallel Bioreactors and Fermentors
Chennai-based VFL Sciences has announced the launch of GreatFlo Parallel, a range of seamlessly parallel Bioreactors and Fermentors at the IKMC 2024 event organised by IKP Knowledge Park at Hyderabad recently, by Dr Jitendra Kumar, Managing Director, BIRAC.
Avantor opens new innovation centre for solving life science's biggest challenges
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, has announced the opening of its new flagship Bridgewater Innovation Centre.
Waters unveils new software to deliver lab-centric business intelligence
Waters Corporation has announced the launch of waters connect Data Intelligence software, a new cloud-based application that helps customers in regulated industries improve how they access, organise, analyse, and drive productivity from laboratory information.
INST develops unique drug delivery method to improve treatment of brain TB
Researchers at the Institute of Nano Science and Technology (INST), Mohali, have created a unique way to deliver Tuberculosis (TB) medicines directly to the brain bypassing the challenging blood-brain barrier (BBB) that limits the effectiveness of many brain TB medicines.
New way to create hydrogels from viral protein fragments for improving drug delivery
Researchers from Bose Institute, an autonomous institute of the Department of Science and Technology (DST), in Kolkata, have discovered a new way to create hydrogels using tiny protein fragments of just five amino acids from the SARS-CoV-1 virus, that could help improve targeted drug delivery & reduce side effects.
Lupin appoints Claus Jepsen as President, Global Specialty
Global pharma major Lupin has announced the appointment of Claus Jepsen as President, Global Specialty.
Shyamakant Giri to join as CEO of Gland Pharma
Gland Pharma’s Board has approved the appointment of Shyamakant Giri, as the new Chief Executive Officer (CEO) of the company.
